Abstract

BackgroundProstate cancer (PCa) is the most frequently diagnosed non-skin cancer and a leading cause of mortality among males in developed countries. However, our understanding of the global changes of protein complexes within PCa tissue specimens remains very limited, although it has been well recognized that protein complexes carry out essentially all major processes in living organisms and that their deregulation drives the pathogenesis and progression of various diseases.MethodsBy coupling tandem mass tagging-synchronous precursor selection-mass spectrometry/mass spectrometry/mass spectrometry with differential expression and co-regulation analyses, the present study compared the differences between protein complexes in normal prostate, low-grade PCa, and high-grade PCa tissue specimens.ResultsGlobally, a large downregulated putative protein–protein interaction (PPI) network was detected in both low-grade and high-grade PCa, yet a large upregulated putative PPI network was only detected in high-grade but not low-grade PCa, compared with normal controls. To identify specific protein complexes that are deregulated in PCa, quantified proteins were mapped to protein complexes in CORUM (v3.0), a high-quality collection of 4274 experimentally verified mammalian protein complexes. Differential expression and gene ontology (GO) enrichment analyses suggested that 13 integrin complexes involved in cell adhesion were significantly downregulated in both low- and high-grade PCa compared with normal prostate, and that four Prothymosin alpha (ProTα) complexes were significantly upregulated in high-grade PCa compared with normal prostate. Moreover, differential co-regulation and GO enrichment analyses indicated that the assembly levels of six protein complexes involved in RNA splicing were significantly increased in low-grade PCa, and those of four subcomplexes of mitochondrial complex I were significantly increased in high-grade PCa, compared with normal prostate.ConclusionsIn summary, to the best of our knowledge, the study represents the first large-scale and quantitative, albeit indirect, comparison of individual protein complexes in human PCa tissue specimens. It may serve as a useful resource for better understanding the deregulation of protein complexes in primary PCa.

Highlights

  • Prostate cancer (PCa) is the most frequently diagnosed non-skin cancer and a leading cause of mortality among males in developed countries

  • The putative protein–protein interaction (PPI) networks of differentially expressed proteins (DEP) The present study revealed that, compared with normal prostate, both low-grade and high-grade PCa have decreased expression of many extracellular matrix (ECM) and plasma membrane proteins, which form large putative PPI networks

  • The negative regulation of apoptotic process (GO:0043066), involving four prothymosin alpha (ProTα) complexes, was found to be significantly upregulated in high-grade PCa compared with normal prostate (Additional file 2: Table S9)

Read more

Summary

Introduction

Prostate cancer (PCa) is the most frequently diagnosed non-skin cancer and a leading cause of mortality among males in developed countries. Owing to the developments and advances in next-generation sequencing technologies, the past few years have witnessed a striking growth of genomic and transcriptomic profiles of clinical PCa specimens [3]. These large-scale efforts enhanced our understanding of the molecular underpinnings of PCa pathogenesis and progression, and facilitated the identification of novel PCa biomarkers and therapeutic targets [4, 5]. Genomic alterations can be prioritized using a systems pharmacology approach combined with targeted proteomics [6], recent studies have suggested that aberrations at the gene copy number, DNA methylation, and RNA expression levels often do not reliably predict changes at the protein expression level [7, 8]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call